Lack of association between cortical amyloid deposition and glucose metabolism in early stage Alzheimer´s disease patients

Ehrlich, Daniela; Dunzinger, Andreas; Malsiner-Walli, Gertraud; Grün, Bettina; Topakian, Raffi; Hodolic, Marina; Kainz, Elmar; Pichler, Robert

doi:10.2478/raon-2021-0051

References

Hardy JA, Higgins GA. Alzheimer’s disease: the amyloid cascade hypothesis. Science 1992; 256: 184-5. doi: 10.1126/science.1566067
Open DOI Search in Google Scholar Back to article
Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 2002; 297: 353-6. doi: 10.1126/science.1072994
Open DOI Search in Google Scholar Back to article
Murphy MP, LeVine H. Alzheimer’s disease and the amyloid-beta peptide. J Alzheimers Dis 2010; 19: 311-23. doi: 10.3233/JAD-2010-1221
Open DOI Search in Google Scholar Back to article
Jack CR Jr, Wiste HJ, Knopman DS, Vemuri P, Mielke MM, Weigand SD, et al. Rates of beta-amyloid accumulation are independent of hippocampal neurodegeneration. Neurology 2014; 82: 1605-12. doi: 10.1212/WNL.0000000000000386
Open DOI Search in Google Scholar Back to article
Altmann A, Ng B, Landau SM, Jagust WJ, Greicius MD. Regional brain hypometabolism is unrelated to regional amyloid plaque burden. Brain 2015; 138: 3734-46. doi: 10.1093/brain/awv278
Open DOI Search in Google Scholar Back to article
Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, et al; Bapineuzumab 301 and 302 Clinical Trial Investigators. Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer’s disease. N Engl J Med 2014; 370: 322-33. doi: 10.1056/NEJMoa1304839
Open DOI Search in Google Scholar Back to article
Nelson PT, Alafuzoff I, Bigio EH, Bouras C, Braak H, Cairns NJ, et al. Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J Neuropathol Exp Neurol 2012; 71: 36281. doi: 10.1097/NEN.0b013e31825018f7
Open DOI Search in Google Scholar Back to article
Cho H, Choi JY, Hwang MS, Lee JH, Kim YJ, Lee HM, et al. Tau PET in Alzheimer disease and mild cognitive impairment. Neurology 2016; 87: 375-83. doi: 10.1212/WNL.0000000000002892
Open DOI Search in Google Scholar Back to article
Schöll M, Ossenkoppele R, Strandberg O, Palmqvist S, Jögi J, Ohlsson T, et al. Distinct 18F-AV-1451 tau PET retention patterns in early- and late-onset Alzheimer’s disease. Brain 2017; 140: 2286-94. doi: 10.1093/brain/awx171
Open DOI Search in Google Scholar Back to article
Saint-Aubert L, Almkvist O, Chiotis K, Almeida R, Wall A, Nordberg A. Regional tau deposition measured by [18F]THK5317 positron emission tomography is associated to cognition via glucose metabolism in Alzheimer’s disease. Alzheimers Res Ther 2016; 8: 38. doi: 10.1186/s13195-016-0204-z
Open DOI Search in Google Scholar Back to article
Jack CR Jr, Petersen RC, Xu YC, O’Brien PC, Smith GE, Ivnik RJ, et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 1999; 52: 1397-403.
Search in Google Scholar Back to article
Villemagne VL, Burnham S, Bourgeat P, Brown B, Ellis KA, Salvado O, et al. Australian Imaging Biomarkers and Lifestyle (AIBL) Research Group. Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer’s disease: a prospective cohort study. Lancet Neurol 2013; 12: 357-67. doi: 10.1016/S1474-4422(13)70044-9
Open DOI Search in Google Scholar Back to article
McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 2011; 7: 263-9. doi: 10.1016/j.jalz.2011.03.005
Open DOI Search in Google Scholar Back to article
Shivamurthy VK, Tahari AK, Marcus C, Subramaniam RM. Brain FDG PET and the diagnosis of dementia. AJR Am J Roentgenol 2015; 204: W76-85. doi: 10.2214/AJR.13.12363
Open DOI Search in Google Scholar Back to article
Ishii K. PET approaches for diagnosis of dementia. AJNR Am J Neuroradiol 2014; 35: 2030-8. doi: 10.3174/ajnr.A3695
Open DOI Search in Google Scholar Back to article
Shaffer JL, Petrella JR, Sheldon FC, Choudhury KR, Calhoun VD, Coleman RE, et al. Predicting cognitive decline in subjects at risk for Alzheimer disease by using combined. Radiology 2013; 266: 583-91. doi: 10.1148/radiol.12120010
Open DOI Search in Google Scholar Back to article
Engler H, Forsberg A, Almkvist O, Blomquist G, Larsson E, Savitcheva I, et al. Two-year follow-up of amyloid deposition in patients with Alzheimer’s disease. Brain 2006; 129: 2856-66. doi: 10.1093/brain/awl178
Open DOI Search in Google Scholar Back to article
Edison P, Archer HA, Hinz R, Hammers A, Pavese N, Tai YF, et al. Amyloid, hypometabolism, and cognition in Alzheimer disease: An [11C]PIB and [18F]FDG PET study. Neurology 2007; 68: 501-8. doi: 10.1212/01.wnl.0000244749.20056.d4
Open DOI Search in Google Scholar Back to article
Cohen AD, Price JC, Weissfeld LA, James J, Rosario BL, Bi W, et al. Basal cerebral metabolism may modulate the cognitive effects of Aβ in mild cognitive impairment: an example of brain reserve. J Neurosci 2009; 29: 14770-8. doi: 10.1523/JNEUROSCI.3669-09.2009
Open DOI Search in Google Scholar Back to article
Deuschl G, Maier W, et al; Steuerungsgruppe. S3- Guideline dementias. [German]. In: German Society for Neurology, editor. Guidelines for diagnostics and therapy in neurology. [German]. 2016. [cited 2021 Sep 12]. Available at: www.dgn.org/leitlinien
Search in Google Scholar Back to article
Folstein MF, Folsten SE, McHugh PR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-98. doi: 10.1016/0022-3956(75)90026-6
Open DOI Search in Google Scholar Back to article
Pichler R, Dunzinger A, Wurm G, Pichler J, Weis S, Nussbaumer K, et al. Is there a place for FET PET in the initial evaluation of brain lesions with unknown significance? Eur J Nucl Med Mol Imaging 2010; 37: 1521-8. doi: 10.1007/s00259-010-1457-6
Open DOI Search in Google Scholar Back to article
Hodolic M, Topakian R, Pichler R. 18F-fluorodeoxyglucose and 18F-flumazenil positron emission tomography in patients with refractory epilepsy. Radiol Oncol 2016; 50: 247-53. doi: 10.1515/raon-2016-0032
Open DOI Search in Google Scholar Back to article
R Core Team. A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2019. [cited 2021 Sep 13]. Available at: http://www.R-project.org/
Search in Google Scholar Back to article
Holm S. A simple sequentially rejective multiple test procedure. Scand J of Stat 1979; 6: 65-70.
Search in Google Scholar Back to article
Murphy MP, LeVine H. Alzheimer’s disease and the amyloid-beta peptide. J Alzheimers Dis 2010; 19: 311-23. doi: 10.3233/JAD-2010-1221
Open DOI Search in Google Scholar Back to article
Dickson TC, Vickers JC. The morphological phenotype of beta-amyloid plaques and associated neuritic changes in Alzheimer’s disease. Neuroscience 2001; 105: 99-107. doi: 10.1016/s0306-4522(01)00169-5
Open DOI Search in Google Scholar Back to article
Vlassenko AG, Benzinger TL, Morris JC. PET amyloid-beta imaging in preclinical Alzheimer’s disease. Biochim Biophys Acta 12012; 1822: 370-9. doi: 10.1016/j.bbadis.2011.11.005
Open DOI Search in Google Scholar Back to article
Lowe SL, Willis BA, Hawdon A, Natanegara F, Chua L, Foster J, et al. Donanemab (LY3002813) dose-escalation study in Alzheimer’s disease. Alzheimers Dement (N Y) 7: e12112. doi: 10.1002/trc2.12112
Open DOI Search in Google Scholar Back to article
Huang LK, Chao SP, Hu CJ. Clinical trials of new drugs for Alzheimer disease. J Biomed Sci 2020; 27: 18. doi: 10.1186/s12929-019-0609-7
Open DOI Search in Google Scholar Back to article
Tomic JL, Pensalfini A, Head E, Glabe CG. Soluble fibrillar oligomer levels are elevated in Alzheimer’s disease brain and correlate with cognitive dysfunction. Neurobiol Dis 2009; 35: 352-8. doi: 10.1016/j.nbd.2009.05.024
Open DOI Search in Google Scholar Back to article
Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Cedarbaum J, et al. 2014 Update of the Alzheimer’s Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimers Dement 2015; 11: e1-120. doi: 10.1016/j.jalz.2014.11.001
Open DOI Search in Google Scholar Back to article
Small GW, Kepe V, Ercoli LM, Siddarth P, Bookheimer SY, Miller KJ, et al. PET of brain amyloid and tau in mild cognitive impairment. N Engl J Med 2006; 355: 2652-63. doi: 10.1056/NEJMoa054625
Open DOI Search in Google Scholar Back to article
Rowe CC, Ackerman U, Browne W, Mulligan R, Pike KL, O’Keefe G, et al. Imaging of amyloid beta in Alzheimer’s disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism. Lancet Neurol 2008; 7: 129-35. doi: 10.1016/S1474-4422(08)70001-2
Open DOI Search in Google Scholar Back to article
Koole M, Lewis DM, Buckley C, Nelissen N, Vandenbulcke M, Brooks DJ, et al. Whole-body biodistribution and radiation dosimetry of 18F-GE067: a radioligand for in vivo brain amyloid imaging. J Nucl Med 2009; 50: 818-22. doi: 10.2967/jnumed.108.060756
Open DOI Search in Google Scholar Back to article
Kung HF, Choi SR, Qu W, Zhang W, Skovronsky D. 18F stilbenes and styrylpyridines for PET imaging of a beta plaques in Alzheimer’s disease: a miniperspective. J Med Chem 2010; 53: 933-41. doi: 10.1021/jm901039z
Open DOI Search in Google Scholar Back to article
Frings L, Hellwig S, Spehl TS, Bormann T, Buchert R, Vach W, et al. Asymmetries of amyloid-β burden and neuronal dysfunction are positively correlated in Alzheimer’s disease. Brain 2015; 138: 3089-99. doi: 10.1093/brain/awv229
Open DOI Search in Google Scholar Back to article
Jack CR Jr, Wiste HJ, Knopman DS, Vemuri P, Mielke MM, Weigand SD, et al. Rates of beta-amyloid accumulation are independent of hippocampal neurodegeneration. Neurology 2014; 82: 1605-12. doi: 10.1212/WNL.0000000000000386
Open DOI Search in Google Scholar Back to article
Scahill RI, Schott JM, Stevens JM, Rossor MN, Fox NC. Mapping the evolution of regional atrophy in Alzheimer’s disease: unbiased analysis of fluid-registered serial MRI. Proc Natl Acad Sci USA 2002; 99: 4703-7. doi: 10.1073/pnas.052587399
Open DOI Search in Google Scholar Back to article
Pearson RC, Esiri MM, Hiorns RW, Wilcock GK, Powell TP. Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease. Proc Natl Acad Sci USA 1985; 82: 4531-4. doi: 10.1073/pnas.82.13.4531
Open DOI Search in Google Scholar Back to article
Kepe V, Moghbel MC, Långström B, Zaidi H, Vinters HV, Huang SC, et al. Amyloid-β positron emission tomography imaging probes: a critical review. J Alzheimers Dis 2013; 36: 613-31. doi: 10.3233/JAD-130485
Open DOI Search in Google Scholar Back to article
Zwan MD, Bouwman FH, Konijnenberg E, van der Flier WM, Lammmertma AA, Verhey FR, et al. Diagnostic impact of [18F]flutemetamol PET in earlyonset dementia. Alzheimers Res Ther 2017; 9: 2. doi: 10.1186/s13195-0160228-4
Open DOI Search in Google Scholar Back to article
Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991; 82: 239-59. doi: 10.1007/BF00308809
Open DOI Search in Google Scholar Back to article
Morbelli S, Bauckneht M, Scheltens P. Imaging biomarkers in Alzheimer’s Disease: added value in the clinical setting. Q J Nucl Med Mol Imaging 2017; 61: 360-71. doi: 10.23736/S1824-4785.17.03011-4
Open DOI Search in Google Scholar Back to article
Bennett DA, Schneider JA, Wilson RS, Bienias JL, Arnold SE. Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function. Arch Neurol 2004; 61: 378-84. doi: 10.1001/archneur.61.3.378
Open DOI Search in Google Scholar Back to article
Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, et al. Amyloid-beta protein dimers isolated directly from Alzheimer’s brains impair synaptic plasticity and memory. Nat Med 2008; 14: 837-42. doi: 10.1038/nm1782
Open DOI Search in Google Scholar Back to article
Braak H, Alafuzoff I, Arzberger T, Kretzschmanr H, Del Tredici K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunhistochemistry. Acta Neuropathol 2006; 112: 389-404. doi: 10.1007/s00401-006-0127-z
Open DOI Search in Google Scholar Back to article
Dronse J, Fliessbach K, Bischof GN, Reutern von B, Faber J, Hammes J, et al. In vivo patterns of tau pathology, amyloid-β burden, and neuronal dysfunction in clinical variants of Alzheimer’s disease. J Alzheimers Dis 2017; 55: 465-71. doi: 10.3233/JAD-160316
Open DOI Search in Google Scholar Back to article
Bejanin A, Schonhaut DR, La Joie R, Kramer JH, Baker SL, Sosa N, et al. Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer’s disease. Brain 2017; 140: 3286-300. doi: 10.1093/brain/awx243
Open DOI Search in Google Scholar Back to article
Huber CM, Yee C, May T, Dhanala A, Mitchell CS. Cognitive decline in preclinical Alzheimer’s disease: amyloid-beta versus tauopathy. J Alzheimers Dis 2018; 61: 265-81. doi: 10.3233/JAD-170490
Open DOI Search in Google Scholar Back to article

Lack of association between cortical amyloid deposition and glucose metabolism in early stage Alzheimer´s disease patients

References

Paradigm

My account